Corpus Intelligence IC Memo — OKEENE MUNICIPAL HOSPITAL 2026-04-26 12:47 UTC
IC Memo — OKEENE MUNICIPAL HOSPITAL
Investment Committee Memorandum | OK | 17 beds | Grade D | EBITDA uplift $516K
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

OKEENE MUNICIPAL HOSPITAL

CCN 371327 | BLAINE, OK | 17 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

OKEENE MUNICIPAL HOSPITAL is a 17-bed rural/critical access in BLAINE, OK with $6.9M in net patient revenue and a -20.0% operating margin. The hospital serves a payer mix of 75.9% Medicare, 1.6% Medicaid, and 22.5% commercial.

Thesis: Turnaround. Our ML models identify $516K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -20.0% to -12.5% (+750bps).

Net Revenue HCRIS$6.9M
Current EBITDA COMPUTED$-1.4M
Operating Margin COMPUTED-20.0%
Occupancy HCRIS8.0%
Revenue / Bed COMPUTED$404K
Net-to-Gross HCRIS79.0%
Distress Probability ML65.2%

2. Market Context & Competitive Position

147
OK Hospitals
-8.8%
State Median Margin
62
Comparable Hospitals

OK has 147 Medicare-certified hospitals with a median operating margin of -8.8%. The target's margin of -20.0% places it below the state median. Among 62 size-comparable peers (8-34 beds), the median margin is -17.9%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (8-34), prioritizing same-state peers. 62 hospitals in the comp set.

HospitalStateBedsRevenueMargin
OKEENE MUNICIPAL HOSPITAL (Target)OK17$6.9M-20.0%
OKLAHOMA SPINE HOSPITALOK23$79.0M8.4%
BAILEY MEDICAL CENTEROK33$54.6M13.3%
BRISTOW MEDICAL CENTEROK25$48.5M-12.6%
JEFFERSON COUNTY HOSPITALOK25$41.1M14.4%
PHYSICIANS HOSPITAL AT ANADARKOK25$34.1M-48.1%
LAKESIDE WOMENS HOSPITALOK23$33.0M16.5%
STROUD REGIONAL MEDICAL CENTEROK25$31.4M-50.0%
SURGICAL HOSPITAL OF OKLAHOMAOK12$31.2M-13.0%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $516K (750bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$144K+210bp18mo
Denial Rate Reduction12.0%6.5%$141K+204bp12mo
Cost to Collect4.5%2.5%$138K+200bp12mo
A/R Days Reduction5200.0%3800.0%$84K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+14bp6mo

5. EBITDA Bridge

Net Collection Rate
$144K
Denial Rate Reduction
$141K
Cost to Collect
$138K
A/R Days Reduction
$84K
Clean Claim Rate
$10K
Total EBITDA Uplift$516K
Current EBITDA$-1.4M
+ RCM Uplift+$516K
Pro Forma EBITDA$-862K
Current Margin-20.0%
Pro Forma Margin-12.5%
WC Released (1x)$264K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-2.1M$-3.9M0.00x-100.0%
Base (11x exit)10.0x11.0x$-2.1M$-5.0M0.00x-100.0%
Bull Case9.0x11.0x$-1.9M$-4.0M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-1.9M$-4.9M0.00x-100.0%
Bear Case11.0x10.0x$-2.3M$-5.8M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-2.3M$-7.2M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumHeavy Medicare dependenceMedicare comprises 75.9% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement
MediumLow occupancyAt 8.0%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 65.2% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 62 hospitals with 8-34 beds
  • Same-state prioritization (n=66)
  • Comp margins: P25=-29.5% / P50=-17.9% / P75=-5.5%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.